Novartis (NVS) P/B (1999 - 2026)
Novartis (NVS) P/B from Nov 1, 1999 to Jul 20, 2026. The TTM Novartis (NVS) P/B is 7.44. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Novartis (NVS)
| Year | P/B | Change |
|---|---|---|
| 2026 | 7.44 | +29.06% |
| 2025 | 5.77 | +30.22% |
| 2024 | 4.43 | -19.35% |
| 2023 | 5.49 | +68.83% |
| 2022 | 3.25 | +11.63% |
| 2021 | 2.91 | -23.49% |
| 2020 | 3.81 | -2.68% |
| 2019 | 3.91 | +53.43% |
| 2018 | 2.55 | -6.91% |
| 2017 | 2.74 | +17.44% |
| 2016 | 2.33 | -13.63% |
| 2015 | 2.70 | -15.79% |
| 2014 | 3.21 | +20.12% |
| 2013 | 2.67 | +18.89% |
| 2012 | 2.25 | +6.04% |
| 2011 | 2.12 | -0.80% |
| 2010 | 2.13 | -0.79% |
| 2009 | 2.15 | -3.98% |
| 2008 | 2.24 | -12.18% |
| 2007 | 2.55 | -27.44% |
| 2006 | 3.52 | +34.65% |
| 2005 | 2.61 | +3.84% |
| 2004 | 2.51 | +10.13% |
| 2003 | 2.28 | +24.94% |
| 2002 | 1.83 | +0.63% |
| 2001 | 1.82 | -18.44% |
| 2000 | 2.23 | +22.18% |
| 1999 | 1.82 | N/A |
Comparison Novartis (NVS) P/B with competitors
Novartis (NVS) P/B is 7.44.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -90.81% |
| GRFS | Grifols SA | 0.79 | -89.38% |
| SNY | Sanofi | 1.27 | -82.93% |
| BIIB | Biogen Inc | 1.52 | -79.59% |
| PFE | Pfizer Inc | 1.55 | -79.20% |
| OGN | Organon & Company | 3.93 | -47.24% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -45.02% |
| GSK | GSK Plc | 4.37 | -41.24% |
| BMY | Bristol-Myers Squibb Company | 6.04 | -18.83% |
| AZN | Astrazeneca plc | 6.20 | -16.67% |
| MRK | Merck & Co Inc | 6.68 | -10.22% |
| GILD | Gilead Sciences Inc | 6.94 | -6.73% |
| JNJ | Johnson & Johnson | 7.64 | +2.68% |
| NSRX | Nasus Pharma Ltd | 12.90 | +73.37% |
| MDCX | MDCorp | 15.34 | +106.16% |
| AMGN | AMGEN Inc | 21.17 | +184.52% |
| SCLX | Scilex Holding Company | 28.85 | +287.73% |
| LLY | Lilly(Eli) & Company | 32.94 | +342.70% |
| ABBV | Abbvie Inc | 50.46 | +578.16% |